Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-22

Clinical Trial Update: Carnosine for Peripheral Arterial Disease Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is recruiting to evaluate carnosine in patients with peripheral artery disease. The study aims to assess safety and early signals of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carnosine (carnosine)

Snippet

Sponsor: Shahid Baba | Conditions: Peripheral Arterial Disease | Phase 1, Phase 2 | Status: RECRUITING